Therapy of ventricular tachycardia in patients with nonischemic cardiomyopathies

Mechanisms underlying spontaneous and induced ventricular arrhythmias in patients with idiopathic dilated cardiomyopathy

BACKGROUND

To define the electrophysiological mechanism(s) of inducible and spontaneously occurring ventricular arrhythmias associated with nonischemic cardiomyopathy, 3-dimensional intraoperative mapping from 156 intramural sites was performed in 6 patients with idiopathic dilated cardiomyopathy undergoing cardiac transplantation.

METHODS AND RESULTS

Electrode density was sufficient to determine the mechanism for 52 of 74 beats of nonsustained ventricular tachycardia (VT) induced by programmed stimulation and 9 of 11 beats of spontaneous ventricular arrhythmias. The first, second, and third extrastimuli (S2 through S4) conducted with progressively greater degrees of conduction delay (total activation times [TAs] of 144+/-5, 166+/-5, and 194+/-5 ms, respectively) owing to slow conduction and on occasion intramural block. The first beats of induced VT arose from subendocardial or subepicardial sites distant from areas of marked conduction delay by a focal mechanism on the basis of the absence of intervening electrical activity between the termination of the last extrastimulus and the initiation of VT (123+/-31 ms). Subsequent beats arose by a focal mechanism and conducted with a TA of 127+/-6 ms (P=NS versus initiating beats of VT [118+/-9 ms]). Spontaneous ventricular arrhythmias initiated in the subendocardium by a focal mechanism and conducted with a TA of 138+/-5 ms. Tissue analysis demonstrated a variable degree of interstitial fibrosis at sites of focal activation. Sites of conduction delay or block typically exhibited marked interstitial and/or replacement fibrosis but were spatially distant from sites initiating VT.

CONCLUSIONS

Spontaneous and induced ventricular arrhythmias in patients with end-stage idiopathic cardiomyopathy can arise in the subendocardium or subepicardium by a focal mechanism.

Primary prevention of sudden cardiac death in heart failure: will the solution be shocking?

Sudden cardiac death (SCD) may occur in as many as 40% of all patients who suffer from heart failure. This review describes the scope of the problem, risk factors for SCD, the effect of medications used in heart failure on SCD and the potential effect of the implantable cardioverter-defibrillator in primary prevention.

Radiofrequency catheter ablation of ventricular tachycardia late after myocardial infarction

Radiofrequency catheter ablation is a promising method for controlling ventricular tachycardia (VT) due to prior myocardial infarction. Limitations of mapping and ablation techniques have largely restricted its use to selected patients who have hemodynamically tolerated sustained monomorphic VT that allows catheter mapping. Multiple monomorphologies of VT, which are usually present, often complicate the ablation procedure and interpretation of ablation effects. Ablation is generally restricted to experienced centers and is usually reserved for patients who have failed other therapies. Despite these difficulties, successful ablation can be life-saving in patients with incessant VT and can markedly improve quality of life with frequent shocks from implantable defibrillators.